Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Richard Respess"'
Autor:
Susan A Fiscus, Ben Cheng, Suzanne M Crowe, Lisa Demeter, Cheryl Jennings, Veronica Miller, Richard Respess, Wendy Stevens, Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group
Publikováno v:
PLoS Medicine, Vol 3, Iss 10, p e417 (2006)
Externí odkaz:
https://doaj.org/article/5b3d1ce6356244d9a34bd9491f2cc913
Autor:
Meryl H. Mendelson, Mari A. Stewart, Walid Heneine, Richard Respess, Brian Koll, Carol Sulis, Jean G. Orelien, Elise M. Beltrami, Denise M. Cardo, Rachanee Cheingsong
Publikováno v:
Infection Control & Hospital Epidemiology. 24:724-730
Objective:To assess the prevalence of HIV antiretroviral resistance among source patients for occupational HIV exposures.Design:Blood and data (eg, stage of HIV, previous antiretroviral drug therapy, and HIV RNA viral load) were collected from HIV-in
Autor:
Chou-Pong Pau, Peter E. Vink, Marc Bulterys, Bart Holland, Trudy Dobbs, Paul Palumbo, Chi-Cheng Luo, Elaine J. Abrams, Richard Respess, Steven Nesheim
Publikováno v:
The Journal of Infectious Diseases. 184:1120-1126
To assess the impact of antiretroviral resistance on perinatal transmission prevention efforts, human immunodeficiency virus type 1 (HIV-1) genotypic resistance testing was done for 220 HIV-1-infected, zidovudine (AZT)-exposed pregnant women and 24 o
Autor:
Walid Heneine, Nicholas S. Hellmann, Christos J. Petropoulos, Jonathan E. Kaplan, Chi-Cheng Luo, Hillard Weinstock, Marta Gwinn, Toni C. Woods, Richard Respess, Chou-Pong Pau
Publikováno v:
The Journal of Infectious Diseases. 182:330-333
To assess the prevalence of mutations associated with decreased antiretroviral drug susceptibility, specimens were tested from persons infected with human immunodeficiency virus (HIV) during 1993-1998. Subjects were drug naive and were attending sexu
Publikováno v:
AIDS Research and Human Retroviruses. 15:133-142
We evaluated the performance of three HIV-1 RNA quantitation methods (Amplicor HIV-1 MONITOR-1.0, NASBA, and Quantiplex HIV RNA 2.0 [branched DNA (bDNA)]) using plasma specimens (N = 60) from individuals from Asia and Africa infected with one of thre
Autor:
Salvatore R. Scianna, Richard Respess, Wendy Stevens, Jörg Schüpbach, Susan A. Fiscus, Ralph Morack, Ada Cachafeiro, Oliviero E. Varnier, Gary E Corrigan, Cheryl Jennings, Suzanne M. Crowe, Donald Brambilla, Michael A. Ussery, A Danilovic, James W. Bremer, J. Simon Gronowitz
Publikováno v:
Journal of clinical microbiology. 43(12)
Human immunodeficiency virus (HIV) RNA testing is the gold standard for monitoring antiretroviral therapy in HIV-infected patients. However, equipment and reagent costs preclude widespread use of the assay in resource-limited settings. The Perkin-Elm
Autor:
Eve M. Lackritz, Robert Downing, Dorothy Ochola, Raymond Mwebaze, Badara Samb, Paul J. Weidle, Catherine Sozi, Jonathan Mermin, Samuel S. Malamba, Brendan Larder, Gideon Rukundo, Kurt Hertogs, Richard Respess
Publikováno v:
AIDS (London, England). 17
Objective: We describe phenotypic drug resistance response to therapy and genotypic mutations among HIV-infected patients in Uganda taking antiretroviral medications for >/= 90 days who had a viral load >/= 1000 copies/ml. Methods: HIV-1 group and su
Autor:
Aissatou Diop, James I. Mullins, Awa M. Coll-Seck, Ibra Ndoye, Richard Respess, Nancy B. Kiviat, Stephen E. Hawes, Cathy W. Critchlow, Mary W. Redman, Mame A. Faye-Niang, Geoffrey S. Gottlieb, Jane Kuypers, Papa Salif Sow
Publikováno v:
The Journal of infectious diseases. 185(7)
Human immunodeficiency virus (HIV) type 2 infection is characterized by slower disease progression to acquired immunodeficiency syndrome than results from HIV-1 infection. To better understand the biological factors underlying the different natural h
Autor:
Danuta Pieniazek, Veronique De Vroey, Kurt Hertogs, Anthony Kebba, Cissy Kityo, Peter Mugyenyi, Richard Respess, Pascale Dehertogh, Brendan Larder, Stuart Bloor, Eve M. Lackritz, Robert W. Downing, Paul J. Weidle
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 26(5)
To characterize HIV-1 phenotypic resistance patterns and genotypic mutations among patients taking antiretroviral medications in Uganda the authors reviewed charts and retrieved archived plasma specimens from patients at an AIDS specialty center wher
Autor:
Chi-Cheng Luo, Richard Respess, Charles A. Schable, John F. Beltrami, Denise M. Cardo, Elise M. Jochimsen
Publikováno v:
Archives of Internal Medicine. 159
Information suggesting that zidovudine postexposure prophylaxis (PEP) reduces the risk of human immunodeficiency virus (HIV) transmission after occupational exposure to HIV-infected blood prompted the US Public Health Service to provide guidelines fo